March 13, 2026 · Blood · DOI: 10.1182/blood.2025031420

Defective cerebrovascular development in mice lacking TFPI is restored by activated protein C

Listen to this summary

The authors investigate whether excess activated protein C (aPC) can rescue cerebrovascular defects in mice lacking Tissue Factor Pathway Inhibitor (Tfpi-/-), which typically leads to embryonic lethality due to thrombin overproduction. They find that while aPC reduces glomeruloid body numbers and improves survival, it does not fully correct all cerebrovascular issues, indicating that TFPI plays a critical and non-redundant role in embryonic angiogenesis and thrombin regulation. The study highlights the complex interplay between coagulation factors and vascular development during embryogenesis.

Susan A Maroney, Nicholas D Martinez, Praveen Krishnamoorthy, Paul Ellery, Mark A Rasmussen, Amy E Siebert, Jennifer May, Erin Yttre, Adrianna M Jurek, Randal J Westrick, Donny Hoang, Shikan Zheng, Mark Zogg, John Patrick Sheehan, James Fitzpatrick, Tongjun Gu, Hartmut Weiler, Alan E Mast

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play